Publications

Human exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.

Pollard, EJ M; PATTERSON, C; Russell, TL; Apairamo, A; Oscar, J; Arcà, B; DRAKELEY, C; Burkot, TR;

2019

Malaria journal, (2019).18 1 10.1186/s12936-019-2975-8.

Regarding response by Dans et. al. to our article, "Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness.".

LARSON, H; Hartigan-Go, K; De Figueiredo, A;

2019

Human vaccines & immunotherapeutics, (2019).15 3 10.1080/21645515.2018.1556079.

Design of Vaccine Efficacy Trials for Priority Emerging and Epidemic Diseases.

Watson, C; Ferguson, N; Donnelly, C; Keeling, M; Tildesley, M; Horby, P; EDMUNDS, J;

2019

TRIALS, (2019).20,

Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya.

Nyiro, JU; Kiyuka, PK; Mutunga, MN; Sande, CJ; Munywoki, PK; SCOTT, JA G; Nokes, DJ;

2019

Wellcome open research, (2019).4, 10.12688/wellcomeopenres.15108.1.

Pneumococcal conjugate vaccine use during humanitarian crises.

VAN ZANDVOORT, K; CHECCHI, F; Diggle, E; EGGO, RM; Gadroen, K; Mulholland, K; MCGOWAN, CR; LE POLAIN DE WAROUX, O; RAO, VB; Satzke, C; FLASCHE, S;

2019

Vaccine, (2019).37 45 10.1016/j.vaccine.2019.09.038.

Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis.

Silaba, M; OOKO, M; BOTTOMLEY, C; Sande, J; Benamore, R; Park, K; Ignas, J; Maitland, K; Mturi, N; Makumi, A; OTIENDE, M; Kagwanja, S; Safari, S; Ochola, V; Bwanaali, T; Bauni, E; Gleeson, F; Deloria Knoll, M; ADETIFA, I; Marsh, K; Williams, TN; Kamau, T; Sharif, S; Levine, OS; Hammitt, LL; ... SCOTT, JA G.

2019

The Lancet Global Health, (2019).7 3 10.1016/S2214-109X(18)30491-1.

An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool.

Bellan, SE; EGGO, RM; Gsell, P-S; KUCHARSKI, AJ; Dean, NE; Donohue, R; Zook, M; EDMUNDS, WJ; Odhiambo, F; Longini, IM; Brisson, M; Mahon, BE; Henao-Restrepo, AM;

2019

Vaccine, (2019).37 31 10.1016/j.vaccine.2019.06.019.

The life-course approach to vaccination: Harnessing the benefits of vaccination throughout life.

Tate, J; Aguado, T; Belie, JD; Holt, D; KARAFILLAKIS, E; LARSON, HJ; Nye, S; Salisbury, D; Votta, M; Wait, S;

2019

Vaccine, (2019).37 44 10.1016/j.vaccine.2019.09.016.

Effect of Schistosoma mansoni infection and its treatment on antibody responses to measles catch-up immunisation in pre-school children: A randomised trial.

Tweyongyere, R; Nassanga, BR; Muhwezi, A; Odongo, M; Lule, SA; Nsubuga, RN; WEBB, EL; COSE, SC; ELLIOTT, AM;

2019

PLoS neglected tropical diseases, (2019).13 2 10.1371/journal.pntd.0007157.

Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls' HPV vaccination programme in England.

PATERSON, P; MOUNIER-JACK, S; Saliba, V; Yarwood, J; White, J; Ramsay, M; CHANTLER, T;